Question follow-through · 81941
Respiratory Syncytial Virus: Vaccination
To ask the Secretary of State for Health and Social Care, what steps he is taking to gather additional data on the (a) effectiveness and (b) safety of the Respiratory Syncytial Virus vaccination in people that are over 80.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 14 Oct 2025
- Target answer date
- 16 Oct 2025
- Answer
- 4 Nov 2025 · 21 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Heart Diseases: Young People · 3 Nov 2025
- Heart Diseases: Young People · 3 Nov 2025
- Health Professions: Regulation · 10 Dec 2025
- Mesothelioma: Medical Treatments · 2 Jan 2026
- Mesothelioma: Nurses · 2 Jan 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
14 Oct 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what steps he is taking to gather additional data on the (a) effectiveness and (b) safety of the Respiratory Syncytial Virus vaccination in people that are over 80.
16 Oct 2025
Target answer date
Date supplied by the official written-questions record.
4 Nov 2025
Answer published
The UK Health Security Agency (UKHSA) undertakes monitoring and evaluation of immunisation programmes, including the effectiveness of vaccines. The Medicines and Healthcare Products Regulatory Agency (MHRA) monitors vaccine safety. The UKHSA and the MHRA ...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Heart Diseases: Young People
3 Nov 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help raise awareness among young people of the risks of sudden cardiac death in (a) grassroots sports clubs and (b) higher education settings.
Heart Diseases: Young People
3 Nov 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to introduce screening for asymptomatic heart conditions in young people in sports settings.
Health Professions: Regulation
10 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made on the potential merits of statutory regulation of therapy titles.
Mesothelioma: Medical Treatments
2 Jan 2026 · To ask the Secretary of State for Health and Social Care, if he will consider establishing a national clinical audit for people living with mesothelioma to understand a) the need for preventative measures and b) the scale of treatment needed.
Mesothelioma: Nurses
2 Jan 2026 · To ask the Secretary of State for Health and Social Care, if he will consider specific funding for mesothelioma nursing posts.
Depressive Illnesses: Ketamine
9 Jan 2026 · To ask the Secretary of State for Health and Social Care, whether he plans to request that NICE conduct an exceptional (expedited) partial review of the NICE Depression guideline (NG222) to consider the inclusion of intravenous racemic ketamine as an opti
Epilepsy: Research
26 Jan 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of increasing funding for epilepsy research.
Lipoedema
9 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether lipoedema has a diagnostic code within NHS data systems; what steps he is taking to improve the collection of data on prevalence, diagnosis and outcomes for people with lipoedema; and what
Lipoedema
9 Feb 2026 · To ask the Secretary of State for Health and Social Care, what training and guidance is provided to GPs and other frontline clinicians on recognising and managing lipoedema; and whether he plans to review undergraduate, postgraduate and continuing profess
Lipoedema
9 Feb 2026 · To ask the Secretary of State for Health and Social Care, how lipoedema is classified within NICE guidance and NHS commissioning frameworks; and whether he plans to review the categorisation of lipoedema-related interventions to ensure they reflect clinic
Prescription Drugs: Cost Effectiveness
20 Feb 2026 · To ask the Secretary of State for Health and Social Care, when his Department plans to release an impact assessment for changes to the NICE cost-effectiveness threshold.
NHS: Finance
3 Mar 2026 · To ask the Secretary of State for Health and Social Care, with reference to the Answer of 1 May 2024 to Question 19413 on NHS: Expenditure, how much NHS England, clinical commissioning groups and integrated care boards spent in aggregate on (a) mental hea